Abstract
Abstract
Background and aims
Molecular imaging of the dopamine transporters (DAT) provides valuable information about neurodegenerative diseases, such as Parkinson’s. This study assessed the accuracy and precision of DAT-SPECT quantification methods.
Methods
Twenty-three DAT-SPECT images of a striatal phantom were acquired. The specific (caudate and putamen) and the non-specific (background activity) chambers were filled with [99mTc]Tc. Different specific-to-non-specific activity ratios (10, 9, 8, 7, 6, 5, 4, 3 and 2 to 1) and the specific binding ratio (SBR) were calculated. Five methods using ROIs were assessed: (a) Manual ROIs on SPECT images; (b) TwoBox and (c) ThreeBox methods and Volume of Interest (VOI) using structural images; (d) MRI and (e) CT. Accuracy was evaluated by the concordance correlation coefficient (CCC) and precision by Pearson’s coefficient and linear regression.
Results
The SBR quantified in the specific and striatal chambers resulted in a CCC increase with a decrease in the nominal values. For lower SBR, MRI and CT showed higher CCCs when caudate ($$\hbox {CCC}_{\mathrm{MRI-CA}}$$
CCC
MRI
-
CA
= 0.89 e $$\hbox {CCC}_{\mathrm{CT-CA}}$$
CCC
CT
-
CA
= 0.84) and putamen ($$\hbox {CCC}_{\mathrm{MRI-PU}}$$
CCC
MRI
-
PU
= 0.86 e $$\hbox {CCC}_{\mathrm{CT-PU}}$$
CCC
CT
-
PU
= 0.82) were evaluated. For striatal assessments, the TwoBox method was the most accurate ($$\hbox {CCC}_{\mathrm{TWOBOX-ST}}$$
CCC
TWOBOX
-
ST
= 0.95). High Pearson’s coefficients were found in the correlations between all methods.
conclusions
All five methods showed high precision even when applied to images with different activities. MRI and CT were the most accurate for assessing the caudate or putamen. To assess the striatal chamber and in the absence of structural information, the TwoBox method is advisable.
Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,Instrumentation,Biomedical Engineering,Radiation
Reference23 articles.
1. Olanow CW, Obeso JA. The significance of defining preclinical or prodromal Parkinson’s disease. Mov Disord. 2012;27(5):666–9. https://doi.org/10.1002/mds.25019.
2. Hornykiewicz O. The role of brain dopamine (3-hydroxytyramine) in parkinsonism. 1964;57–68. https://doi.org/10.1016/B978-0-08-010804-9.50008-5
3. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002;125(4):861–70. https://doi.org/10.1093/brain/awf080.
4. Arkadir D, Bergman H, Fahn S. Redundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson disease. Neurology. 2014;82(12):1093–8. https://doi.org/10.1212/WNL.0000000000000243.
5. Bieńkiewicz M, Górska-Chrza̧stek M, Siennicki J, Gajos A, Bogucki A, Mochecka-Thoelke A, Płachcińska A, Kuśmierek J. Impact of ct based attenuation correction on quantitative assessment of datscan ($$<$$sup$$>$$123$$<$$/sup$$>$$i-ioflupane) imaging in diagnosis of extrapyramidal diseases. Nuclear Med Rev. 2008;11(2):53–8.